InsidersTradesSigma
Follow the 科前生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 科前生物 has published 1 reports. Market capitalisation: €5.9bn. The latest transaction was reported on 19 July 2024 (Sale). Among the most active insiders: 叶长发. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
科前生物是一家专注于健康和制药领域的公司，致力于创新生物解决方案的研发。该公司在XSHG市场上市。